Published in Health Business Week, March 26th, 2004
Watson's nicotine polarcrilex gum is used as an aid for smoking cessation. Terms of the agreement were not disclosed.
"We are pleased to have Novartis Consumer Health as our marketing partner on our nicotine gum," said Joe Papa, Watson's president and chief operating officer. "As a result, we are now able to make this product available to those over-the-counter customers we do not...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.